Methyldrostanolone 10

Methyldrostanolone is contraindicated in patients with:

• Severe liver disease or dysfunction
• Prostate or breast cancer
• Hypersensitivity to methyldrostanolone or any of its components

Caution is advised in patients with a history of cardiovascular, renal, or other medical conditions that may be exacerbated by the use of AAS.

Patients should be closely monitored for signs of liver damage, lipid changes, and other adverse reactions. Discontinuation may be necessary if significant side effects occur.

The recommended dosage range for Methyldrostanolone is typically 10-20 mg per day, taken orally in divided doses. Treatment duration is usually limited to 4-6 weeks due to the risk of hepatic strain.

Methyldrostanolone is a controlled substance with a high potential for abuse. It should only be used under proper medical supervision for legitimate medical purposes.